Cover Image

heidarzadehroozbeh-cmyk/ML-Prognostic_Biomarkers-for-Serous-OvarianCancer: Version 1.1 – Machine Learning Pipeline for HGSC Prognostic Biomarker Discovery

Fuente: Zenodo

Saved in:

Bibliographic Details
Main Author:	Roozbeh Heidarzadehpilehrood
Format:	Recurso digital
Published:	Zenodo 2026
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Host Index and Gallbladder Cancer: An Emerging Prognostic Biomarker
by: Abhay K. Kattepur, et al.
Published: (2025)

Exploring Molecular Signature and Prognostic Biomarkers in Ovarian Cancer: Insights From Late‐Stage, Recurrent, and Metastatic Tumors
by: Vandana Yadav, et al.
Published: (2026)

Prognostic and Predictive Value of Machine Learning‐Based Biomarker and Pathomics Signatures in Patients With Prostate Cancer
by: Jianpeng Zhang, et al.
Published: (2025)

Identification of Prognostic Biomarkers in Gene Expression Profile of Neuroblastoma Via Machine Learning
by: Shuxin Tang, et al.
Published: (2025)

Deubiquitinase Genes as Prognostic Biomarkers in Osteosarcoma: Insights From Single‐Cell Sequencing and Machine Learning–Based Prognostic Modeling
by: Meng Zhang, et al.
Published: (2025)

Immunoreactivities of ZCCHC3 and Efp in the High‐Grade Serous and Clear Cell Ovarian Carcinomas Are Worse Prognostic Factors
by: Erina Iwabuchi, et al.
Published: (2026)

Glycosylation Gene Signatures as Prognostic Biomarkers in Glioblastoma
by: Tong Zhao, et al.
Published: (2025)

Editorial: Hyperferritinaemia—An Ironclad Biomarker for the Prognostication of MASLD?
by: Mark C. C. Cheah, et al.
Published: (2025)

Optimizing Prognostic Biomarker Discovery in Pancreatic Cancer Through Hybrid Ensemble Feature Selection and Multi-Omics Data
by: Zobolas, John, et al.
Published: (2025)

GGTLC1 Is a Prognostic Biomarker in Renal Clear Cell Carcinoma
by: Shi Li, et al.
Published: (2025)

Computational Mapping of Reactive Stroma in Prostate Cancer Yields Interpretable, Prognostic Biomarkers
by: Pleasure, Mara, et al.
Published: (2026)

Multiomics Identification of Radioresistance‐Associated Biomarkers and Prognostic Model Construction in Rectal Cancer
by: Zongxueni Deng, et al.
Published: (2026)

Advancing Cancer Management: The Dual Diagnostic‐Prognostic Potential of Nucleic Acid Biomarkers
by: Yongle Shao, et al.
Published: (2026)

The Emerging Role of Tertiary Lymphoid Structures as Predictive and Prognostic Biomarkers of Immunotherapy in Cancer
by: Lidia B. Medhin, et al.
Published: (2026)

Integrative Pan-Cancer Analysis of RNMT: a Potential Prognostic and Immunological Biomarker
by: Huang, Shuqiang, et al.
Published: (2022)

HCCS Serves as Potential Prognostic Biomarker and Therapeutic Target in Human Breast Cancer
by: Sm Faysal Bellah, et al.
Published: (2025)

CXCL13 as a Prognostic Biomarker and Modulator of the Tumor Microenvironment in Colorectal Cancer
by: Fang Fang Guo, et al.
Published: (2025)

SMPD1 as a Potential Prognostic Biomarker in Glioma Is Associated With an Immunosuppressive Microenvironment
by: Yanan Xu, et al.
Published: (2026)

Novel Prognostic and Predictive miRNA Biomarkers Shape the Landscape of T Cell Dysfunction in Cancer
by: Hong‐jiu Wang, et al.
Published: (2026)

Pan‐Cancer Analysis Reveals SKA3 as a Potential Diagnostic and Prognostic Biomarker
by: Chunlin Li, et al.
Published: (2025)

Identification of MDM4 as a Prognostic Biomarker and a Target for Therapeutics in Colorectal Cancer
by: Xiao Shang, et al.
Published: (2025)

Developing an Explainable Prognostic Model for Acute Ischemic Stroke: Combining Clinical and Inflammatory Biomarkers With Machine Learning
by: Linlin Ma, et al.
Published: (2025)

Diagnostic and Prognostic Values of Bile Biomarkers for Malignant Biliary Stenosis
by: E. Gigante, et al.
Published: (2026)

LGMN as a Functionally Significant Prognostic and Immunoregulatory Biomarker in Glioma
by: Chenyi Nie, et al.
Published: (2025)

Identification of PPFIA3 as a Potential Prognostic and Immune Biomarker Through Pan‐Cancer Analysis
by: Xianghong Wang, et al.
Published: (2025)

Prognostic Biomarker of Fertility‐Preserving Hormonal Therapy Based on Multigene Panel Testing for Endometrial Cancer
by: Takuro Hirano, et al.
Published: (2025)

DHCR7 as a Prognostic and Immunological Biomarker in Human Pan‐Cancer: A Comprehensive Evaluation
by: Xianghua Wu, et al.
Published: (2025)

Editorial for “Assessing the Diagnostic Value of MRI T1rho Mapping in Predicting Molecular Prognostic Biomarkers and Subtypes of Breast Cancer”
by: Robert E. Lenkinski, et al.
Published: (2025)

Prognostic Biomarkers for Anti‐ PD ‐1 Monoclonal Antibodies in the First Line Treatment of Advanced Melanoma
by: Marek Pásek, et al.
Published: (2025)

Serum Midkine as a Biomarker for Hepatocellular Carcinoma Treatment Response and Prognostication
by: Yanfang Luo, et al.
Published: (2026)

Prediction and Prognostication of Acute Graft‐Versus‐Host Disease by MAGIC Biomarkers
by: John E. Levine
Published: (2025)

Single‐Cell RNA Sequencing Reveals LEF1 as a Prognostic Biomarker for Poor Outcomes in Oxaliplatin‐Resistant Colorectal Cancer
by: Pin Huang, et al.
Published: (2025)

Retracted: DNM1: A Prognostic Biomarker Associated with Immune Infiltration in Colon Cancer—A Study Based on TCGA Database
by: BioMed Research International
Published: (2024)

Prognostic Significance of Pretreatment Blood‐Based Biomarkers in Penile Cancer: A Multicenter Retrospective Study in Japan
by: Shuichi Tatarano, et al.
Published: (2026)

The Expression and Clinical Significance of C1orf106 in Low‐Grade Serous Ovarian Cancer
by: Feifei Song, et al.
Published: (2025)

The Immune‐Related Gene CD48 Is a Prognostic Biomarker Associated With the Breast Cancer Tumor Microenvironment
by: Yi Zhao, et al.
Published: (2025)

The Identification of Novel Prognostic and Predictive Biomarkers in Breast Cancer via the Elucidation of Tumor Ecotypes Using Ecotyper
by: Feng Du, et al.
Published: (2025)

Prognostic Value of Trop‐2 Expression in Nonmetastatic Triple‐Negative Breast Cancer and Correlation With Emerging Biomarkers
by: William Jacot, et al.
Published: (2025)

CCL18 and EGF May Serve as Potential Prognostic Biomarkers and Therapeutic Targets for Human Breast Cancer
by: Sm Faysal Bellah, et al.
Published: (2025)

The NLRP1 Emerges as a Promising Therapeutic Target and Prognostic Biomarker Across Multiple Cancer Types: A Comprehensive Pan‐Cancer Analysis
by: Leila Habibipour, et al.
Published: (2025)